ndothelial cell (EC)-mediated vasodilation of arteries can generally be achieved either through production of nitric oxide (NO), endothelial-derived hyperpolarization (EDH), or a combination of these pathways. NO is produced by eNOS (endothelial NO synthase) and diffuses to smooth muscle cells (SMCs) to promote vasodilation by binding to its cytosolic receptor soluble guanylyl cyclase, which produces cyclic guanosine monophosphate.
1 EDH refers to a signaling pathway that typically begins with the opening of small-and intermediateconductance calcium-activated potassium channels (SK Ca and IK Ca , respectively) on ECs, leading to the efflux of potassium ions from SMCs. [2] [3] [4] [5] Hyperpolarization of smooth muscle because of reduced cytosolic positive charge leads to dilation. Both mechanisms of dilatory signals described above must be tightly regulated throughout the vascular tree to maintain blood pressure homeostasis. It has been established that the relative contribution of these endothelial-mediated vasodilatory mechanisms differs based on the size of the vessel; large conduit arteries such as the carotid and aorta rely on NO signaling to dilate, whereas in smaller, resistance arteries like the mesenteric arteries, EDH is an additional and important mechanism of dilation. [1] [2] [3] 
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An anatomic difference exists in the structure of the conduit and resistance arteries that may account for the difference in functional dilation. ECs in resistance arteries have unique signaling microdomains termed myoendothelial junctions (MEJs) that penetrate the fibrous internal elastic lamina (IEL) to make heterocellular contact with SMCs via gap junctions. [6] [7] [8] [9] [10] This direct heterocellular contact allows for electrochemical communication between ECs and SMCs to facilitate vasodilation predominantly through the EDH pathway (reviewed extensively 4, [11] [12] [13] [14] ).
In contrast, conduit arteries have a significantly reduced number of MEJs compared with resistance arteries, as well as a significantly thicker IEL (up to 5 μm in the aorta compared to ≈0.5 μm in resistance arteries) that allows them to handle high transmural pressures in proximity to the heart. [15] [16] [17] [18] Conduit arteries preferentially dilate via the NO pathway, presumably because NO is a highly diffusible signaling molecule that can cross the multiple thick IEL layers. 14, [19] [20] [21] [22] In contrast, the expression of alpha globin in ECs of resistance arteries may provide a constraint on the ability of NO to diffuse from endothelium to smooth muscle, limiting the role of NO in this setting. [22] [23] [24] Our laboratory has previously demonstrated that PAI-1 (plasminogen activator inhibitor-1) is enriched at the MEJ and that its depletion results in decreased MEJ formation. 25, 26 However, it remains to be demonstrated whether PAI-1 is sufficient to induce MEJ formation. In this study, we investigate the formation of IEL holes in the carotid (a conduit artery) after the direct application of PAI-1 in live mice. We observed transient formation of EC projections (resembling MEJs) after 7 days that retreat by day 21. Interestingly, an increased proportion of non-NO, EDH-based arterial relaxation accompanies this anatomic phenotype. Additionally, we have demonstrated that alpha globin expression in the carotid arteries upon induction of EC projections can dictate NO or EDH-based vasodilation. Thus, we have established a model of MEJ formation through the direct application of PAI-1 to a conduit artery and have shown that functional heterocellular contact is correlated with increased reliance on EDH-mediated pathways.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Please see Online Methods for extensive details on the experiments used in this article.
Mice
All mice and procedures were approved by the University of Virginia Animal Care and Use Committee. Male C57Bl/6 (Taconic Biosciences) and Hba1 −/− (Jackson Labs) mice were used between 10 and 12 weeks of age. Male mice were used in this study for consistency in comparison of results to our previous work, as well as to minimize possible variability given N values.
Plasminogen Activator Inhibitor-1
Lyophilized PAI-1 (500 IU, Technoclone, Vienna) powder was reconstituted by addition of 200 μL distilled water followed by gentle agitation for 5 minutes at room temperature (2.5×10 6 IU/L stock solution) that yields enzyme in its active form for ≈12 hours or being bound to vitronectin. Forty microliter per tube aliquots were stored at −70°C. At 4°C immediately before use, 40 μL stock solution of PAI-1 was mixed with 460 μL of sterile saline solution containing 35% F127 Pluronic Gel (Molecular Probes).
Mouse Surgery
Mice were anesthetized with an intraperitoneal injection of a freshly made ketamine/xylazine mixture (Fort Dodge; final concentration 80 mg/kg and Vedco; final concentration 6 mg/kg, respectively). The pluronic gel/PAI-1 mixture (preparation described above) and pipettes were kept at 4°C and placed on ice just before use. While holding the carotid artery (CA) away from surrounding tissues, the pluronic gel/ PAI-1 mixture (100 IU PAI-1 in 500 μL or 2×10 5 IU/L solution) or pluronic gel (500 μL of 35% pluronic gel) was topically applied to the outside of the left CA and solidified within 1 minute of application. Pluronic gel/PAI-1 mixture or pluronic gel only was kept on CAs 
Novelty and Significance
What Is Known?
• Internal elastic lamina holes and myoendothelial junctions are hallmarks of resistance arteries, but both are sparse in conduit arteries.
• Endothelial-mediated vasodilation occurs in resistance arteries largely via endothelial derived hyperpolarization and predominantly through nitric oxide in larger arteries.
• Endothelial alpha globin is predominately observed at the level of resistance arteries.
What New Information Does This Article Contribute?
• Internal elastic lamina holes and endothelial cell projections (ie, myoendothelial junctions) can form in conduit arteries after in vivo treatment with PAI-1 (plasminogen activator inhibitor-1).
• The mechanism of endothelial-mediated vasodilation is dependent on cellular contact between endothelium and smooth muscle.
• Alpha globin may in part regulate the altered signaling mechanisms in resistance and conduit arteries.
Our data demonstrate that PAI-1 induces the carotid artery, a conduit artery, to phenocopy the arterial wall structure and function of a resistance artery; this includes holes in the internal elastic lamina, endothelial cell projections (ie, myoendothelial junctions), and switching to predominantly endothelial-derived hyperpolarization vasodilation. PAI-1-treated carotid arteries further resembled resistance arteries with alpha globin expression. Using PAI-1-treated carotid arteries from a global alpha globin knockout mouse, arterial relaxation predominantly occurred through nitric oxide signaling, suggesting a role for alpha globin in facilitating the switch to predominately endothelial-derived hyperpolarization-based relaxation.
for 1, 2, 3, 4, 5, 7, 14, or 21 days. At the end of the pluronic gel/PAI-1 or gel only incubation, mice were euthanized using CO 2 asphyxia and CAs were carefully removed (see Online Methods). Once free of surrounding tissues and cleaned, the CA was used for a variety of experiments (see Online Figure I for visual representation). Carotids for pressure myography were ≈500 μm in diameter and 5 mm in length.
Visualizing Holes and MEJs
To visualize IEL holes and MEJs, the following 3 methods were used: (1) fluorescent detection of IEL holes using Alexa Fluor 633 hydrazide (Molecular Probes) and confocal microscopy, (2) scanning electron microscopy of endothelial denuded CA, and (3) transmission electron microscopy on intact CAs to visualize endothelial extensions.
Measurements of CA Vasoreactivity
CAs were isolated after treatment as described above and cannulated in a pressure myograph chamber (Danish MyoTechnology). 27 To evaluate the effect of PAI-1 on the vasoreactivity of CA, where indicated, experiments were conducted in the presence or absence of selective blockers of endothelium-mediated vasodilator pathways. To block NO generation alone, we used the NOS (NO synthase) inhibitor l-nitro-arginine methyl ester (l-NAME; 300 µmol/L; Sigma). To block both NO generation and the EDH pathway, we used (1) the cyclooxygenase inhibitor indomethacin (10 µmol/L; Sigma), (2) the IK Ca blocker 1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole (TRAM-34; 10 µmol/L; Sigma), (3) the SK Ca channel blocker apamin (300 nmol/L), and (4) l-NAME. After a 30-minute stabilization period in the circulating bath, the arteries were preconstricted with 50 μmol/L phenylephrine followed by cumulative concentrations of acetylcholine (Ach; 10 -9 to 10 -4 mol/L). To activate IK Ca and SK Ca channels, NS309 (3 µmol/L) was added to preconstricted CAs. All vessels were then washed with a Ca 
Biocytin Dye Transfer
CAs were removed per above, cannulated, and flushed with Ca 2+ -free Krebs-HEPES buffer, followed by perfusion through with new buffer supplemented with 0.01% Tween20+2.68 mmol/L (1 mg/mL) biocytin for 15 minutes at room temperature. After washing the lumen and bath with Ca 2+ -free Krebs-HEPES buffer, CAs were fixed in 4% paraformaldehyde for an hour at room temperature, washed in phosphate-buffered saline (PBS), and cut open longitudinally with the endothelium en face. Next, they were permeabilized in PBS containing 0.01% TritonX-100 for 30 minutes followed by an hour incubation in 1:500 streptavidin conjugated to Alexa Fluor 568 (also in PBS with 0.01% TritonX-100). CAs were imaged with a Olympus Fluoview 1000 confocal microscope.
Western Blot
Blotting was performed as previously described 28 and is briefly described in the Online Methods.
Statistics
For in vivo experiments, animals were randomly assigned groups by an independent third party. An independent researcher performed vasoreactivity or morphology, and scores were re-assigned to treatment groups afterward. Power analysis was performed (α=0.05; >20% change) to determine group sizes and study power (>0.80) using G*Power. 29, 30 Thus, some experiments only required an N=3 while others required N≥4. One-way ANOVA followed by Tukey's multiple comparisons test or 2-way ANOVA followed by Sidak's multiple comparisons test were used as necessary. For non-gaussian distributed data (Shapiro-Wilk normality test), nonparametric statistical tests were used and indicated in the figure legend (Kruskal-Wallis test followed by Dunn's multiple comparisons test). Analysis was performed using GraphPad Prism version 7.0 for Mac OS X (GraphPad Software, La Jolla, CA) with P<0.05 considered significantly different. Data are expressed as mean±SEM.
Results

Functional MEJs Form in the IEL of Carotid Arteries After Application of PAI-1
Like other conduit arteries, CAs have a thick IEL separating the endothelium and smooth muscle and contain very few MEJs. 31, 32 We have previously demonstrated that PAI-1 can regulate the formation of MEJs. 25 Using a pluronic gel, we applied PAI-1 to CAs of C57Bl/6 mice to determine whether these conduit arteries could form MEJs, and if so, whether they were functional (Online Figure I) . PAI-1 was found throughout the carotid wall after application (Online Figure II) . We initially screened for extent of hole formation in the IEL after PAI-1 application via autofluorescence of carotids laid en face (Online Figure III) . We found that the maximum number of holes could be identified 7 days after PAI-1 application to CAs. After 7 days, the number of holes steadily regressed more than halfway to baseline by 21 days post-PAI-1 application. Based on these results, we used time points at 0, 1, 7, and 21 days after PAI-1 application for further experiments. Through visualizing the IEL with autofluorescence, we quantified holes in the IEL, which we found to be significantly increased 7 days post-application of PAI-1 ( Figure 1A through 1G ). We confirmed the formation of holes in the CA IEL by imaging carotids stripped of endothelium with scanning electron microscopy ( Figure 1H through 1N ). It has previously been shown that not all IEL holes contain MEJ protein markers. 12 Therefore, we sectioned CAs in transverse at each of the time points and identified EC extensions through the IEL (Figure 1O through 1U) . We observed a significant increase in the number of EC projections at day 7 after PAI-1 treatment, but these EC projections were transient, as their number reverted almost to baseline by day 21 with PAI-1. Although resembling MEJs, the EC projections could not be observed to physically touch SMC (Online Figure IV) , likely due to width of the cellular projection when heterocellular contact was made. The sizes of the IEL holes in conduit arteries after PAI-1 was similar to those found in mesenteric or skeletal muscle beds (Online Figure V) . These changes that occurred were independent of the thickness of the IEL (Online Figure VI) , and normal EC-EC junctions (eg, VEcadherin) were preserved (Online Figure VII) . Overall, exogenous PAI-1 application to the CA was sufficient to induce the formation of endothelial projections through the lamina of the CA. These projections are normally restricted to small diameter arterioles and resistance arteries.
Although we could identify increased endothelial projections at day 7 of PAI-1 treatment, it was unknown if they made functional heterocellular contact. One important test of functional heterocellular contact at MEJs is the coupling of ECs to SMCs through gap junctions. Thus, we examined dye transfer from ECs to SMCs as an indicator of functional gap junction channels. ECs of a cannulated CA were loaded with biocytin using a pinocytotic method that loads >90% of ECs (Molecular Probes). A small, uncharged molecule, biocytin, can traverse gap junctions, and due to its biotin moiety, it can be detected with fluorescently labeled streptavidin. Because of the lack of MEJs and heterocellular gap junctional communication in CAs at day 0, we were not able to observe biocytin in the SMC layer (Figure 2A and 2B) . However, at day 7 post-PAI-1 application, we were able to measure biocytin transfer from ECs to SMCs via fluorescent signal present in the SMC layer. Although there are no truly specific pharmacological means to block gap junctions, (eg, Billaud et al 32 and Behringer et al 33 ), the addition of α-glycyrrhetinic acid, a purported gap junction inhibitor, prevented the biocytin dye transfer (Figure 2A and 2B). Thus, the EC projections that we observed can couple ECs to SMCs, presumably allowing dye to pass through heterocellular gap junction channels. Next, we wanted to test for functional heterocellular contact using a vasoreactivity approach to assess changes in relaxation to NS309 (an activator of SK Ca and IK Ca channels; 3 µmol/L). Application of NS309 tests whether EDH signaling is active between endothelium and smooth muscle by inducing endothelial hyperpolarization to achieve subsequent smooth muscle vasodilation. 34 Sham-or gel-treated CAs did not relax more to NS309 treatment compared with vessels from day 0 PAI-1-treated animals ( Figure 2C) . However, at day 7 post-PAI-1 application, NS309 induced a significant increase in relaxation, which was lost The XY-plane of endothelium is shown in the top row and smooth muscle in the one below. Note the addition of α-glycyrrhetinic acid (α-GA) blocked biocytin transfer to smooth muscle in carotids treated with PAI-1 for 7 days. Scale bar is 20 μm. A Kruskal-Wallis test followed by Dunn's multiple comparisons test was used to establish significance. B, Percent streptavidin-positive smooth muscle cells per 10 000 μm 2 after loading of endothelium with biocytin. C, Carotids were stimulated with 3 μmol/L NS309, and relaxation was measured. Each dot on the graphs in (B and C) indicates the average of 3 random fields of view from 1 mouse, minimum N=3 mice per experimental condition. Note the addition of α-GA, and denuding endothelium, prevented relaxation of carotids treated with PAI-1 for 7 days. In each graph, *P<0.05.
after denuding endothelium or adding α-glycyrrhetinic acid. Day 21 CAs also did not have a significant NS309 relaxation. In addition, Cx40 was observed in the holes of the IEL after 7 days of PAI-1 (Online Figure VII) . Thus, we can correlate the formation of IEL holes and corresponding EC projections (both seen maximally at day 7 post-PAI-1 application) with functional EC and SMC coupling.
MEJs Are Necessary, but Not Sufficient, to Alter Endothelial-Induced Dilation
In arteries with many MEJs (eg, resistance arteries), endothelial derived vasodilation using cholinergic stimulation (via Ach) is mainly through EDH, 4, [12] [13] [14] whereas in arteries with few MEJs, NO signaling predominates. 1, 3 We reasoned that the new formation of endothelial projections (MEJs) in a conduit artery could alter the endothelial-dependent mechanism of vasodilation. Dose responses with Ach on control CAs (ie, sham, pluronic gel only, or carotids with few MEJs) demonstrated that eNOS inhibition alone (with 300 μmol/L l-NAME, a nonspecific NOS inhibitor) largely blunted relaxation (Figure 3A and 3B; Online Figure VIII ). This is a widely described finding in CAs and other conduit arteries that demonstrate endothelialderived vasodilation dominated by NO signaling. 20, 35 However, at day 7 after PAI-1 application, when holes in the carotid IEL and EC projections were maximally present and heterocellular dye transfer and relaxation to NS309 both were significantly increased, l-NAME alone showed a reduced ability to inhibit relaxation. It was only with the addition of apamin, TRAM-34, and indomethacin (SK CA , IK CA , cyclooxygenase inhibitors, respectively) that the Ach response was significantly inhibited (Figure 3A and 3B; Online Figure VIII) . In experiments on CAs treated with PAI-1 for 7 days, an inhibitory response was observed with the combination of indomethacin, TRAM-34, and apamin, as well as with only TRAM-34, apamin, or l-NAME (Online Figure IX) . This predominance of non-NObased relaxation is usually only observed in resistance arteries where MEJs are prevalent.
Lastly, we tested whether the formation of MEJs alone was sufficient to alter the mechanism for endothelial-derived vasodilation. We have previously demonstrated that alpha globin is a potent NO scavenger and is present in resistance arteries, with little to no expression in conduit arteries. 22, 24 At day 7 post-PAI-1 application, when MEJs and Ach-induced non-NO vasodilation are maximal, we found a significant increase in the expression of alpha globin ( Figure 4A and 4B) . We also observed alpha globin in the holes of the IEL at day 7 (Online Figure VII) . In mice with a disrupted Hba1 gene (Hba1 −/− ), we found no alpha globin expression at day 7 post-PAI-1 application, whereas in littermate controls (Hba1 +/+ ), the protein was produced at normal levels similar to that seen in C57Bl/6 (Figure 4A and 4B; Online Figure X) . Importantly, the absence of alpha globin expression at day 7 post-PAI-1 application in Hba1 −/− mice had no effect on (1) the number of holes in the IEL that were present ( Figure 4C and 4D) , (2) EC projections into the IEL ( Figure 4E ), (3) dye transfer to SMC (Figure 4F ), or (4) relaxation to NS309 ( Figure 4G ). However, Figure 3 . When myoendothelial junctions are present in carotids, acetylcholine-induced relaxation is no longer reliant on nitric oxide. A, Doseresponse curves to acetylcholine (Ach); black circles are untreated control carotids, blue triangles are carotids treated with l-nitro-arginine methyl ester (l-NAME), and red squares are carotids treated with l-NAME plus the inhibitors 1-[(2-chlorophenyl)-diphenylmethyl]-1H-pyrazole (TRAM-34), indomethacin, and apamin. N values indicate the number of carotids. In all experiments, a minimum of N=3 mice were used per time point per experimental condition. B, Representative traces of Ach dose-response curves in the presence of l-NAME; green arrow is initial phenylephrine (PE) constriction (in %), with each Ach dose indicated by a blue arrow. Red arrows indicate perfusion with Ca 2+ -free buffer. *P<0.05 indicates control compared with l-NAME, TRAM-34, indomethacin, and apamin; #P<0.05 indicates control compared with L-NAME.
CAs of mice lacking alpha globin expression were unable to switch their dominant vasodilatory mechanism from NO to non-NO dominated. As expected, CAs from Hba +/+ littermate controls 7 days after PAI-1 application appeared similar to those seen in C57Bl/6 ( Figure 4H) , with non-NO signaling dominating the vasodilatory response. In Hba1 −/− mice at the Figure 4 . Induction of alpha globin expression within heterocellular contacts regulates nitric oxide diffusion but not myoendothelial junction formation. A, Western blot for alpha globin from carotids, with VE-cadherin used as loading control for endothelium. In the right panel, expression of alpha globin at 7 days post-PAI-1 (plasminogen activator inhibitor-1) application is shown in samples from Hba1 +/+ and Hba1 −/− mice. Arrows indicate 10 kDa for alpha globin and 100 kDa for VE-cadherin. B, Note the significant increase in alpha globin 7 days after PAI-1 treatment that decreases by day 21, matching hole, and endothelial projection prevalence. C-D, The number of holes in the internal elastic lamina (IEL) were assessed via fluorescent microscopy (C) and SEM (D). E, Endothelial projections down into the IEL were assessed the same way as in Figure 1 . Coupling of endothelium and smooth muscle was experimentally determined using biocytin dye transfer (F) and relaxation to NS309 (G). In B-G, colors indicate identical time points; black is day 0 after PAI-1 on a C57Bl/6 mouse, gray is day 7 after PAI-1 on a C57Bl/6 mouse, brown is day 7 after PAI-1 on a Hba +/+ mouse, and pink is day 7 after PAI-1 on a Hba −/− mouse. In (H and I), carotid arteries (CAs) were collected from Hba +/+ (H) or HBA1 −/− (I) mice 7 days after PAI-1 application, cannulated, pressurized, and tested in the presence of l-nitro-arginine methyl ester (l-NAME) or l-NAME with the inhibitors, indomethacin, TRAM-34, and apamin. Loss of alpha globin had no effect on the number of holes in the IEL, cellular extensions, dye transfer, or NS309 induced relaxation (intermediate-conductance/small-conductance calcium-activated potassium channels [IK Ca /SK Ca ]), indicating myoendothelial junctions (MEJs) were still capable of forming (C-G). However, data in H-I demonstrate that the mechanism of endothelial vasodilation was altered without alpha globin present. In all cases, each dot on graphs in C-E) indicates the average of 3 random fields of view from 1 mouse. In F-G, each dot represents 1 mouse. In F, a Kruskal-Wallis test followed by Dunn's multiple comparisons test was used to establish significance in each graph. SEM indicates scanning electron microscopy; and TEM, transmission electron microscopy In F, * and #, P<0.05. In B-G, * indicates control compared with respective carotid treatment. In H and I, * indicates control compared with inhibitors l-NAME, TRAM-34, indomethacin, and apamin; # indicates control compared with L-NAME.
same treatment time point, l-NAME alone was able to significantly blunt relaxation, indicating that NO was still the dominant dilatory pathway ( Figure 4I ). Thus, MEJs are an important component of enabling EC-driven SMC vasodilation. Through limiting the role of NO signaling, the expression of alpha globin at MEJs may facilitate non-NO based signaling (eg, EDH) to predominate in resistance arteries.
Discussion
We have previously demonstrated that PAI-1 is enriched in MEJs. 25 In this study, we further investigated the involvement of PAI-1 in MEJ formation by directly applying recombinant PAI-1 to the CAs of mice via pluronic F-127 gel, a useful medium that can deliver high concentrations of PAI-1 to carotid arteries while avoiding adverse systemic effects. The local increase in PAI-1 at the CA resulted in major phenotypic shifts in structure and function to make this conduit resemble a resistance artery. For example, CAs normally have very few holes in the IEL, nor EC projections (ie, MEJs) through those holes; however, after 7 days of PAI-1 treatment, both of these anatomic phenomena developed. In addition, indications of direct heterocellular coupling between endothelium and smooth muscle were also apparent. This included Cx40 expression in the newly formed IEL holes, blocked biocytin transfer with gap junction inhibition via glycyrrhetinic acid, and NS309 dilation. However, direct evidence of heterocellular contact via electrical coupling (eg, Welsh and Segal 5 and Emerson and Segal 36 ) could not be demonstrated. Regardless, the significant upregulation of IEL holes, endothelial projections, and functional heterocellular coupling represents an important anatomic and functional shift in a conduit artery.
It is not clear why the IEL holes are temporary, but it could represent either a degradation of the exogenously applied PAI-1, PAI-1 binding to vitronectin, or a PAI-1-induced inflammatory response; this will require elaboration in future studies. However, this temporal loss of the IEL holes formed after PAI-1 treatment speaks to the dynamic nature of IEL holes/MEJs and the potential necessity of a constant stimulus to maintain the ability to form MEJs. Here, we report not only an increase in IEL holes but also the formation of endothelial projections. It has previously been shown that not all IEL holes contain markers for MEJ proteins. 11 Although this article does not address the proportion of IEL holes that contain MEJ markers, the significant upregulation of endothelial projections is itself an important anatomic change. Because exogenous application of PAI-1 alone induces formation of IEL holes and MEJ-like projections within the carotid, this represents an important advancement in our understanding of the development of these critical vascular signaling microdomains. The spatial distribution of PAI-1 across the vascular wall may be one such avenue to explore; with PAI-1's local translation and enrichment at MEJs, 26 it is possible that the MEJ signaling domain may be capable of regulating its own formation.
Functionally, the induction of endothelial projections (ie, MEJs) in the carotid was able to introduce a larger contribution of EDH into the vasodilatory component of these conduit arteries. Pressure myography experiments revealed relaxation via the IK Ca /SK Ca -channel activator NS309 only in PAI-1-treated CAs at 7 days posttreatment. In addition, l-NAME, an inhibitor of NO production, was unable to prevent vasodilation via the Ach pathway in PAI-1-treated carotids. These pressure myography results indicate a switch from primarily NO-based signaling, normally characteristic of conduit arteries, to a predominantly EDH-based mechanism, characteristic of resistance arteries. The correlation of this switch in dilatory mechanism alongside increased MEJ formation mimics the anatomic and functional observations of resistance vessels; thereby, implicating the MEJ as a potentially critical endothelial signaling microdomain that determines the dominant dilatory pathway of arteries.
Interestingly, increased alpha globin expression was also detected in CAs after PAI-1 treatment. Alpha globin expression is normally limited to resistance arteries but not conduit arteries. 37 Alpha globin has been shown to complex with eNOS to regulate NO signaling in the resistance vasculature. 23, 24 Its expression at the MEJ may act to finely control vasodilation by limiting the diffusion of eNOS-derived NO to the SMC. 37 Contact between ECs and SMCs is required for the expression of alpha globin in ECs, 22, 38 and in the newly formed EC projections that resulted from PAI-1 treatment, alpha globin expression is significantly increased which correlated with limited dilatory effect of NO ( Figure 4H ). However, in mice with a disrupted alpha globin gene product (due to the insertion of a neomycin cassette into exon 2 of the Hba1 gene), the dependence on NO signaling is not lost: relaxation is almost completely blunted with l-NAME alone, with little additive effect from EDH inhibitors ( Figure 4I ). Within the vasculature, cellcell interactions induce protein expression to influence cellular function, 22, [38] [39] [40] [41] and our results embody this motif: alpha globin expression is induced upon heterocellular contact (EC-SMC coupling) and alters cellular function (altered mechanism of arterial relaxation). These data also fit well with previous work demonstrating alpha globin's regulation of eNOS 23, 24 and suggests that alpha globin expression is important for EDH-based signaling to predominate. Indeed, disruption of the alpha globin/eNOS interaction via a mimetic peptide leads to increased NO signaling in resistance arteries. 24, 37 Based on this and the data we show here, alpha globin at newly formed endothelial projections in PAI-1-treated carotids likely participates in the switch to EDH-based relaxation through limiting the effects of NO-based vasodilation. It is also possible that the PAI-1 enzyme may be simultaneously acting on eNOS to reduce NO availability, enhancing the inhibitory effect to ensure EDH predominates. The interaction between PAI-1 and eNOS may be an interesting avenue to explore in future studies.
Since the major anatomic differences between a conduit and resistance artery include the IEL and points of heterocellular contact via MEJs, our finding that the induction of EC projections (ie, MEJs) can switch a conduit artery's dilatory mechanism from NO-dominated to EDH-dominated demonstrates a match between form and function. Our data suggest that MEJs with alpha globin are an important signaling microdomain and could be the reason why EDH predominates in resistance arteries.
